Is the integration of lymphocyte/monocyte ratio and international prognostic score effective in predicting prognosis for hodgkin's lymphoma in the modern era? A prospective cohort study
BACKGROUND: Determining the prognosis of Hodgkin's Lymphoma (HL) is crucial to avoid overtreatment and undertreatment, both of which have dangerous effects on the patient's health. This justifies the many studies to find prognostic factors, which in turn contribute to making the appropriat...
Main Authors: | Hasan Khalil, Firas Hussein, Suzan Samra |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2022-01-01
|
Series: | Journal of Applied Hematology |
Subjects: | |
Online Access: | http://www.jahjournal.org/article.asp?issn=1658-5127;year=2022;volume=13;issue=4;spage=201;epage=207;aulast=Khalil |
Similar Items
-
Post-Treatment Neutrophil and Lymphocyte Counts Predict Progression-Free Survival Following First-Line Chemotherapy in Hodgkin’s Lymphoma
by: Grace Fangmin Tan, et al.
Published: (2023-02-01) -
Hodgkin Disease—An Ever-Evolving Therapy
by: Eldad J. Dann
Published: (2014-10-01) -
Prognostic value of lymphocyte-monocyte ratio at diagnosis in Hodgkin lymphoma: a meta-analysis
by: Shing Fung Lee, et al.
Published: (2019-04-01) -
Long‐term overall survival and toxicities of ABVD vs BEACOPP in advanced Hodgkin lymphoma: A pooled analysis of four randomized trials
by: Marc P. E. André, et al.
Published: (2020-09-01) -
High frequency of primary refractory disease and low progression-free survival rate of Hodgkin's lymphoma: a decade of experience in a Latin American center
by: José Carlos Jaime-Pérez, et al.